American Association for Cancer Research
15417786mcr170380-sup-186496_2_supp_4329970_hxrh7h.docx (216.35 kB)

Supplementary Materials and Methods, Figures S1 - S2, Tables S1 - S4 from Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression

Download (216.35 kB)
journal contribution
posted on 2023-04-03, 16:44 authored by David A. Drew, Allen Mo, James J. Grady, Richard G. Stevens, Joel B. Levine, Bruce M. Brenner, Joseph C. Anderson, Faripour Forouhar, Michael J. O'Brien, Thomas J. Devers, Daniel W. Rosenberg

Supplementary Figure S1. Endoscopic counts of aberrant crypt foci (ACF) by colonic location stratified by the presence of at least one proximal ACF. Supplementary Figure S2. Polyp counts according to the presence of at least one histologically confirmed proximal ACF. Supplementary Table S1. Histologic Distribution of Biopsied Aberrant Crypt Foci. Supplementary Table S2. Polyp Location and Histology Distribution in Study Population. Supplementary Table S3. Synchronous polyps within subjects with a confirmed proximal ACF mutation. Supplementary Table S4. Synchronous polyps within subjects without an ACF mutation.





Aberrant crypt foci (ACF) are the earliest morphologically identifiable lesion found within the human colon. Despite their relatively high frequency in the distal colon, few studies have examined the molecular characteristics of ACF within the proximal colon. In the following study, clinical participants (n = 184) were screened for ACF using high-definition chromoendoscopy with contrast dye-spray. Following pathologic confirmation, ACF biopsies were subjected to laser capture microdissection (LCM), and epithelial cells were evaluated for somatic mutations with a customized colorectal cancer mutation panel using DNA-mass spectrometry. Samples were further characterized for microsatellite instability (MSI). Logistic models were used to associate proximal ACF with synchronous (detected during the same procedure) neoplasia. Thirty-nine percent of participants had at least one histologically confirmed proximal ACF. Individuals with a proximal ACF were significantly more likely to present with a synchronous neoplasm (P = 0.001), and specifically, a proximal, tubular, or tubulovillous adenoma (multivariable OR = 2.69; 95% confidence interval, 1.12–6.47; P = 0.027). Proximal ACF were more likely to be dysplastic (52%) compared with distal ACF (13%; P < 0.0001). Somatic mutations to APC, BRAF, KRAS, NRAS, and ERBB2 were detected in 37% of proximal ACF. Hyperplastic ACF were more often MSI-high, but there were no differences in MSI status observed by colonic location. In summary, ACF are identified in the proximal colons of approximately 40% of individuals undergoing chromoendoscopy and more often in patients with synchronous proximal adenomas.Implications: This study provides the most complete set of data, to date, that ACF represent the earliest step in the adenoma–carcinoma sequence but remain below the detection limit of conventional endoscopy.Visual Overview: http// Mol Cancer Res; 16(3); 486–95. ©2017 AACR.